Indications for control mechanisms in purine and pyrimidine biosynthesis as revealed by studies with inhibitors.
D000818:Animals; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002264:Carboxylic Acids; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism; D005492:Folic Acid / Q000378:metabolism; D005493:Folic Acid Antagonists; D006801:Humans; D007700:Kinetics; D008954:Models, Biological; D009963:Orotic Acid; D011687:Purines / Q000096:biosynthesis*; D011743:Pyrimidines / Q000096:biosynthesis*; D051381:Rats; D013449:Sulfonamides / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology; D014500:Uracil Nucleotides
D002264:Carboxylic Acids; D005493:Folic Acid Antagonists; D011687:Purines; D011743:Pyrimidines; D013449:Sulfonamides; D014500:Uracil Nucleotides; D009963:Orotic Acid; D005492:Folic Acid; D014295:Trimethoprim; D002262:Carboxy-Lyases